Global Blood screening Market Research and Forecast 2018-2023
Blood screening is the process of testing of blood units to ensure the safety of collected blood. The donated blood is required to be screened in order to check the presence of various biomarkers, infections in the blood units. The screened blood when pass the screening tests is preserved and used by blood banks, hospitals and laboratories. The rising prevalence of infectious diseases and demand for safe blood units is major driver for the growth of market. The rapid adoption of latest screening technologies such as nucleic acid amplification test and awareness about blood donations are also some of the factors behind the growth of market. The complex regulations and high initial set up cost for blood bank and screening test is the major restraining factor, however the advancement in latest screening processes such as microbiology screening and increase in government expenditure in healthcare will create more growth opportunity.
The market is divided into North America, Europe, Asia Pacific and Rest of the World geographically. The North American region dominates the global blood screening market due to the rising prevalence of infectious diseases and the advanced healthcare technologies. The extended support of government and rapid adoption of advanced screening test such as nucleic acid amplification test is also propelling the market in the region. The countries such as India and China in Asia pacific region is expected to grow tremendously in the forecasted period due to rapid development of healthcare infrastructure and awareness about blood donations.
The company engaged in Blood screening market provides various types screening tests such as nucleic acid amplification test, ELISA, PCR-RNA and western blotting, the organization also manufactures reagents and testing instruments. The Key Players in the Blood screening market are Abbott Laboratories, Acris Antibodies GmbH, Becton Dickinson and Company, BioAim Scientific Inc, BioMerieux, Inc, Bio-Rad Laboratories, Inc, BioVision Inc, Boster Biological Technology, Cusabio Technology LLC, Danaher Corporation, Demeditec Diagnostics GmbH, F. Hoffmann-La Roche Ltd., Grifols, IBL-America and so on.
RESEARCH METHODOLOGY
The market study of Global Blood screening market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include:
Financial reports of companies involved in the market
Authentic Public Databases (org, gov and other such websites)
Whitepapers, research-papers and news blogs
Company websites and their product catalogue.
The Report is intended for Emerging companies and researchers in the market, Investing companies, Government Organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, growth opportunity in market, product types. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.
MARKET SEGMENTATION:
Global Blood screening Market is segmented on the basis of various regions and below mentioned segments:
Global Blood screening Market Research and Analysis, By Screening technology
Global Blood screening Market Research and Analysis, By End users
Global Blood screening Market Research and Analysis, By Product
THE REPORT COVERS:
Comprehensive research methodology of Global Blood screening market
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Blood screening
Insights about market determinants which are stimulating the Global Blood screening
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.
The market is divided into North America, Europe, Asia Pacific and Rest of the World geographically. The North American region dominates the global blood screening market due to the rising prevalence of infectious diseases and the advanced healthcare technologies. The extended support of government and rapid adoption of advanced screening test such as nucleic acid amplification test is also propelling the market in the region. The countries such as India and China in Asia pacific region is expected to grow tremendously in the forecasted period due to rapid development of healthcare infrastructure and awareness about blood donations.
The company engaged in Blood screening market provides various types screening tests such as nucleic acid amplification test, ELISA, PCR-RNA and western blotting, the organization also manufactures reagents and testing instruments. The Key Players in the Blood screening market are Abbott Laboratories, Acris Antibodies GmbH, Becton Dickinson and Company, BioAim Scientific Inc, BioMerieux, Inc, Bio-Rad Laboratories, Inc, BioVision Inc, Boster Biological Technology, Cusabio Technology LLC, Danaher Corporation, Demeditec Diagnostics GmbH, F. Hoffmann-La Roche Ltd., Grifols, IBL-America and so on.
RESEARCH METHODOLOGY
The market study of Global Blood screening market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include:
Financial reports of companies involved in the market
Authentic Public Databases (org, gov and other such websites)
Whitepapers, research-papers and news blogs
Company websites and their product catalogue.
The Report is intended for Emerging companies and researchers in the market, Investing companies, Government Organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, growth opportunity in market, product types. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.
MARKET SEGMENTATION:
Global Blood screening Market is segmented on the basis of various regions and below mentioned segments:
Global Blood screening Market Research and Analysis, By Screening technology
Global Blood screening Market Research and Analysis, By End users
Global Blood screening Market Research and Analysis, By Product
THE REPORT COVERS:
Comprehensive research methodology of Global Blood screening market
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Blood screening
Insights about market determinants which are stimulating the Global Blood screening
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.
1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATION
2.3.1.1. UNITED STATES
2.3.1.2. EUROPEAN UNION
2.3.1.3. CHINA
2.3.1.4. INDIA
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. SAFETY CONCERN REGARDING BLOOD CONTAMINATION
3.1.2. INCREASING PREVALENCE OF INFECTIOUS DISEASES
3.1.3. ADOPTION OF NUCLEIC ACID AMPLIFICATION TEST
3.1.4. RISING AWARENESS ABOUT BLOOD DONATIONS
3.1.5. TECHNOLOGICAL ADVANCEMENT IN SCREENING TECHNOLOGY SUCH AS MICROBIOLOGY SCREENING.
3.2. RESTRAINT
3.2.1. COMPLEXITY IN REGULATIONS
3.2.2. HIGH INITIAL INVESTMENT FOR BLOOD BANKS
3.3. OPPORTUNITY
3.3.1. INCREASING GOVERNMENT INITIATIVES AND INVESTMENT
3.3.2. MICROFLUID TECHNOLOGIES ARE CHANGING THE BLOOD SCREENING INDUSTRY
4. MARKET SEGMENTATION
4.1. GLOBAL BLOOD SCREENING MARKET, BY SCREENING TECHNOLOGY
4.1.1. NUCLEIC ACID AMPLIFICATION TEST
4.1.2. WESTERN BLOTTING
4.1.3. ENZYME-LINKED IMMUNOSORBENT ASSAY
4.1.4. PCR-RNA
4.2. GLOBAL BLOOD SCREENING MARKET, BY END-USERS
4.2.1. BLOOD BANKS
4.2.2. HOSPITALS
4.2.3. LABORATORIES
4.3. GLOBAL BLOOD SCREENING MARKET, BY PRODUCTS
4.3.1. TESTING INSTRUMENTS
4.3.2. REAGENTS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.2. EUROPE
6.2.1. UK
6.2.2. GERMANY
6.2.3. SPAIN
6.2.4. FRANCE
6.2.5. ITALY
6.2.6. REST OF EUROPE
6.3. APAC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. REST OF APAC
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. ABBOTT LABORATORIES
7.2. ACRIS ANTIBODIES GMBH
7.3. BECTON DICKINSON AND COMPANY
7.4. BIOAIM SCIENTIFIC INC
7.5. BIOMERIEUX, INC
7.6. BIO-RAD LABORATORIES, INC
7.7. BIOVISION INC
7.8. BOSTER BIOLOGICAL TECHNOLOGY
7.9. CUSABIO TECHNOLOGY LLC
7.10. DANAHER CORPORATION
7.11. DEMEDITEC DIAGNOSTICS GMBH
7.12. F. HOFFMANN-LA ROCHE LTD.
7.13. GRIFOLS
7.14. IBL-AMERICA
7.15. INNOVATIVE RESEARCH
7.16. KOMABIOTECH
7.17. ORTHO-CLINICAL DIAGNOSTICS, INC.
7.18. RAYBIOTECH, INC.
7.19. SIEMENS AG
7.20. THERMO FISHER SCIENTIFIC
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATION
2.3.1.1. UNITED STATES
2.3.1.2. EUROPEAN UNION
2.3.1.3. CHINA
2.3.1.4. INDIA
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. SAFETY CONCERN REGARDING BLOOD CONTAMINATION
3.1.2. INCREASING PREVALENCE OF INFECTIOUS DISEASES
3.1.3. ADOPTION OF NUCLEIC ACID AMPLIFICATION TEST
3.1.4. RISING AWARENESS ABOUT BLOOD DONATIONS
3.1.5. TECHNOLOGICAL ADVANCEMENT IN SCREENING TECHNOLOGY SUCH AS MICROBIOLOGY SCREENING.
3.2. RESTRAINT
3.2.1. COMPLEXITY IN REGULATIONS
3.2.2. HIGH INITIAL INVESTMENT FOR BLOOD BANKS
3.3. OPPORTUNITY
3.3.1. INCREASING GOVERNMENT INITIATIVES AND INVESTMENT
3.3.2. MICROFLUID TECHNOLOGIES ARE CHANGING THE BLOOD SCREENING INDUSTRY
4. MARKET SEGMENTATION
4.1. GLOBAL BLOOD SCREENING MARKET, BY SCREENING TECHNOLOGY
4.1.1. NUCLEIC ACID AMPLIFICATION TEST
4.1.2. WESTERN BLOTTING
4.1.3. ENZYME-LINKED IMMUNOSORBENT ASSAY
4.1.4. PCR-RNA
4.2. GLOBAL BLOOD SCREENING MARKET, BY END-USERS
4.2.1. BLOOD BANKS
4.2.2. HOSPITALS
4.2.3. LABORATORIES
4.3. GLOBAL BLOOD SCREENING MARKET, BY PRODUCTS
4.3.1. TESTING INSTRUMENTS
4.3.2. REAGENTS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.2. EUROPE
6.2.1. UK
6.2.2. GERMANY
6.2.3. SPAIN
6.2.4. FRANCE
6.2.5. ITALY
6.2.6. REST OF EUROPE
6.3. APAC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. REST OF APAC
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. ABBOTT LABORATORIES
7.2. ACRIS ANTIBODIES GMBH
7.3. BECTON DICKINSON AND COMPANY
7.4. BIOAIM SCIENTIFIC INC
7.5. BIOMERIEUX, INC
7.6. BIO-RAD LABORATORIES, INC
7.7. BIOVISION INC
7.8. BOSTER BIOLOGICAL TECHNOLOGY
7.9. CUSABIO TECHNOLOGY LLC
7.10. DANAHER CORPORATION
7.11. DEMEDITEC DIAGNOSTICS GMBH
7.12. F. HOFFMANN-LA ROCHE LTD.
7.13. GRIFOLS
7.14. IBL-AMERICA
7.15. INNOVATIVE RESEARCH
7.16. KOMABIOTECH
7.17. ORTHO-CLINICAL DIAGNOSTICS, INC.
7.18. RAYBIOTECH, INC.
7.19. SIEMENS AG
7.20. THERMO FISHER SCIENTIFIC
LIST OF TABLES
TABLE 1 GLOBAL BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY SCREENING TECHNOLOGY,2017-2023($ MILLION)
TABLE 2 GLOBAL NUCLEIC ACID AMPLIFICATION TEST MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 3 GLOBAL WESTERN BLOTTING MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 4 GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 5 GLOBAL PCR-RNA MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 6 GLOBAL BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY END-USERS ,2017-2023($ MILLION)
TABLE 7 GLOBAL BLOOD BANKS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 8 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 9 GLOBAL LABORATORIES MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 10 GLOBAL BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY PRODUCTS ,2017-2023($ MILLION)
TABLE 11 GLOBAL TESTING INSTRUMENTS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 12 GLOBAL REAGENTS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 13 NORTH AMERICA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY SCREENING TECHNOLOGY, 2017-2023($ MILLION)
TABLE 14 NORTH AMERICA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY END-USERS, 2017-2023($ MILLION)
TABLE 15 NORTH AMERICA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY PRODUCTS, 2017-2023($ MILLION)
TABLE 16 EUROPE BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY SCREENING TECHNOLOGY, 2017-2023($ MILLION)
TABLE 17 EUROPE BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY END-USERS, 2017-2023($ MILLION)
TABLE 18 EUROPE BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY PRODUCTS, 2017-2023($ MILLION)
TABLE 19 ASIA PACIFIC BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY SCREENING TECHNOLOGY, 2017-2023($ MILLION)
TABLE 20 ASIA PACIFIC BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY END-USERS, 2017-2023($ MILLION)
TABLE 21 ASIA PACIFIC BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY PRODUCTS, 2017-2023($ MILLION)
TABLE 22 REST OF THE WORLD (ROW) BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 1 GLOBAL BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY SCREENING TECHNOLOGY,2017-2023($ MILLION)
TABLE 2 GLOBAL NUCLEIC ACID AMPLIFICATION TEST MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 3 GLOBAL WESTERN BLOTTING MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 4 GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 5 GLOBAL PCR-RNA MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 6 GLOBAL BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY END-USERS ,2017-2023($ MILLION)
TABLE 7 GLOBAL BLOOD BANKS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 8 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 9 GLOBAL LABORATORIES MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 10 GLOBAL BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY PRODUCTS ,2017-2023($ MILLION)
TABLE 11 GLOBAL TESTING INSTRUMENTS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 12 GLOBAL REAGENTS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 13 NORTH AMERICA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY SCREENING TECHNOLOGY, 2017-2023($ MILLION)
TABLE 14 NORTH AMERICA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY END-USERS, 2017-2023($ MILLION)
TABLE 15 NORTH AMERICA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY PRODUCTS, 2017-2023($ MILLION)
TABLE 16 EUROPE BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY SCREENING TECHNOLOGY, 2017-2023($ MILLION)
TABLE 17 EUROPE BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY END-USERS, 2017-2023($ MILLION)
TABLE 18 EUROPE BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY PRODUCTS, 2017-2023($ MILLION)
TABLE 19 ASIA PACIFIC BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY SCREENING TECHNOLOGY, 2017-2023($ MILLION)
TABLE 20 ASIA PACIFIC BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY END-USERS, 2017-2023($ MILLION)
TABLE 21 ASIA PACIFIC BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY PRODUCTS, 2017-2023($ MILLION)
TABLE 22 REST OF THE WORLD (ROW) BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
LIST OF FIGURES
FIGURE 1 GLOBAL BLOOD SCREENING MARKET SHARE, BY SCREENING TECHNOLOGY, 2017 VS 2023($ MILLION)
FIGURE 2 GLOBAL BLOOD SCREENING MARKET SHARE, BY END USERS, 2017 VS 2023($ MILLION)
FIGURE 3 GLOBAL BLOOD SCREENING MARKET SHARE, BY PRODUCTS, 2017 VS 2023($ MILLION)
FIGURE 4 NORTH AMERICA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 5 UNITED STATES BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 6 CANADA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 7 EUROPE BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 8 UK BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 9 GERMANY BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 10 SPAIN BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 11 FRANCE BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 12 ITALY BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 13 REST OF EUROPE (ROE) BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 14 ASIA PACIFIC BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 15 INDIA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 16 CHINA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 17 JAPAN BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 18 ROAPAC BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 19 REST OF THE WORLD BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
COMPANIES MENTIONED
1. ABBOTT LABORATORIES
2. ACRIS ANTIBODIES GMBH
3. BECTON DICKINSON AND COMPANY
4. BIOAIM SCIENTIFIC INC
5. BIOMERIEUX, INC
6. BIO-RAD LABORATORIES, INC
7. BIOVISION INC
8. BOSTER BIOLOGICAL TECHNOLOGY
9. CUSABIO TECHNOLOGY LLC
10. DANAHER CORPORATION
11. DEMEDITEC DIAGNOSTICS GMBH
12. F. HOFFMANN-LA ROCHE LTD.
13. GRIFOLS
14. IBL-AMERICA
15. INNOVATIVE RESEARCH
16. KOMABIOTECH
17. ORTHO-CLINICAL DIAGNOSTICS, INC.
18. RAYBIOTECH, INC.
19. SIEMENS AG
20. THERMO FISHER SCIENTIFIC
FIGURE 1 GLOBAL BLOOD SCREENING MARKET SHARE, BY SCREENING TECHNOLOGY, 2017 VS 2023($ MILLION)
FIGURE 2 GLOBAL BLOOD SCREENING MARKET SHARE, BY END USERS, 2017 VS 2023($ MILLION)
FIGURE 3 GLOBAL BLOOD SCREENING MARKET SHARE, BY PRODUCTS, 2017 VS 2023($ MILLION)
FIGURE 4 NORTH AMERICA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 5 UNITED STATES BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 6 CANADA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 7 EUROPE BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 8 UK BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 9 GERMANY BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 10 SPAIN BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 11 FRANCE BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 12 ITALY BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 13 REST OF EUROPE (ROE) BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 14 ASIA PACIFIC BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 15 INDIA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 16 CHINA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 17 JAPAN BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 18 ROAPAC BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 19 REST OF THE WORLD BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
COMPANIES MENTIONED
1. ABBOTT LABORATORIES
2. ACRIS ANTIBODIES GMBH
3. BECTON DICKINSON AND COMPANY
4. BIOAIM SCIENTIFIC INC
5. BIOMERIEUX, INC
6. BIO-RAD LABORATORIES, INC
7. BIOVISION INC
8. BOSTER BIOLOGICAL TECHNOLOGY
9. CUSABIO TECHNOLOGY LLC
10. DANAHER CORPORATION
11. DEMEDITEC DIAGNOSTICS GMBH
12. F. HOFFMANN-LA ROCHE LTD.
13. GRIFOLS
14. IBL-AMERICA
15. INNOVATIVE RESEARCH
16. KOMABIOTECH
17. ORTHO-CLINICAL DIAGNOSTICS, INC.
18. RAYBIOTECH, INC.
19. SIEMENS AG
20. THERMO FISHER SCIENTIFIC
